A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor…
30 December 2022 Read more
Currently Recruiting
A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of…
1 December 2022 Read more
Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …
24 June 2021 Read more
Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study (PACIFIC-STROKE)…
7 July 2021 Read more
QUALITY IN ACUTE STROKE CARE (QASC) AUSTRALIA TRIAL Principal Investigator: Prof Sandy Middleton The Quality in Acute Stroke Care (QASC)…
12 April 2023 Read more
Extensive research is being conducted in search of neuroprotective agents for possible use in the acute phase of stroke and…
9 December 2025 Read more
